Biomarkers for vitiligo
US11624751B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2020 |
| Grant date | Apr 11, 2023 |
| Priority date | — |
| Expiry date | Aug 15, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/207
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Biomarkers are provided that are associated with or predictive of a subject's responsiveness to a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing vitiligo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.